Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent expiration for Optinose Us drug XHANCE appeared first on DrugPa…
New patent expiration for Optinose Us drug XHANCE Read Post »
Annual Drug Patent Expirations for FINACEA Finacea is a drug marketed by Leo Pharma As and is included in two NDAs. It is available from three suppliers. There are eight…
The post New patent expiration for Leo Pharma drug FINACEA appeared first on Drug…
New patent expiration for Leo Pharma drug FINACEA Read Post »
Sugammadex sodium is the generic ingredient in two branded drugs marketed by Msd Sub Merck, Aspiro, Mylan, and Sandoz and, and is included in four NDAs. There is one patent…
The post New tentative approval for Sandoz drug sugammadex sodium appeared fir…
New tentative approval for Sandoz drug sugammadex sodium Read Post »
Sugammadex sodium is the generic ingredient in two branded drugs marketed by Msd Sub Merck, Aspiro, Mylan, and Sandoz and, and is included in four NDAs. There is one patent…
The post New tentative approval for Sandoz drug sugammadex sodium appeared fir…
New tentative approval for Sandoz drug sugammadex sodium Read Post »
Sugammadex sodium is the generic ingredient in two branded drugs marketed by Msd Sub Merck, Aspiro, Mylan, and Sandoz and, and is included in four NDAs. There is one patent…
The post New tentative approval for MYLAN drug sugammadex sodium appeared firs…
New tentative approval for MYLAN drug sugammadex sodium Read Post »
Sugammadex sodium is the generic ingredient in two branded drugs marketed by Msd Sub Merck, Aspiro, Mylan, and Sandoz and, and is included in four NDAs. There is one patent…
The post New tentative approval for MYLAN drug sugammadex sodium appeared firs…
New tentative approval for MYLAN drug sugammadex sodium Read Post »
This chart shows the patent expirations for injectable dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
The post Injectable dosed drug patent expirations by year appeared first on DrugPate…
Injectable dosed drug patent expirations by year Read Post »
Sugammadex sodium is the generic ingredient in two branded drugs marketed by Msd Sub Merck, Aspiro, Mylan, and Sandoz and, and is included in four NDAs. There is one patent…
The post New tentative approval for Sandoz drug sugammadex sodium appeared fir…
New tentative approval for Sandoz drug sugammadex sodium Read Post »
Sugammadex sodium is the generic ingredient in two branded drugs marketed by Msd Sub Merck, Aspiro, Mylan, and Sandoz and, and is included in four NDAs. There is one patent…
The post New tentative approval for MYLAN drug sugammadex sodium appeared firs…
New tentative approval for MYLAN drug sugammadex sodium Read Post »
This chart shows the drugs with the most patents in Malaysia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Malays…
Which pharmaceutical drugs have the most drug patents in Malaysia? Read Post »
Get new actionable insights and updates from BiotechBlog
